Amsterdam UMC Joins the ICPC

• Post by: OPL
• July 17, 2019
• Comments off

Amsterdam UMC has joined 32 other institutions around the world to be a part of the International Cancer Proteogenome Consortium (ICPC). The ICPC uses standardized/harmonized proteogenomic approaches and data sharing platforms with its member institutions to accelerate the understanding of the molecular basis of cancer and its translation to improve patient care. Amsterdam UMC will utilize its robust and reproducible workflows to study cancers of interest and priority in the Netherlands. We are excited to have them on our team – because cancer knows no borders. Click here to learn more.